Exterior View of Qizhouke International Pharmaceutical Group Building, Laos

Qizhouke International Pharmaceutical Group Sole Co., Ltd. is an enterprise specializing in cross-border generic drug retail and supply chain. Headquartered in Vientiane, Laos, it leverages the geographical advantages of Vientiane and the Boten Special Economic Zone of Laos to build a China-Laos cross-border pharmaceutical channel in strategic collaboration with India Goshi Group.

Enterprise Background & Organizational Structure

1. Affiliation and CooperationIt maintains in-depth strategic cooperation and joint operation ties with Hong Kong Qizhouke and India Goshi International Group. The Group owns a full industrial ecosystem including Qizhouke Pharmacy Laos, Qizhouke Overseas Warehouse, and Qizhouke International Mall e-commerce platform. On August 20, 2024, after more than half a year of site selection and decoration, Qizhouke Pharmacy Boten (Laos) officially opened its doors, marking the official launch of its generic drug supply business.

2. Registration & Geographical LayoutQizhouke Pharmacy is located in Boten Special Economic Zone, Luang Namtha Province, Laos, merely 200 meters away from the China border port. The Group has also set up business nodes in Hong Kong (cross-border pharmaceutical e-commerce), Hainan and Guangzhou (cross-border e-commerce).

3. Compliance & QualificationsThe enterprise holds officially issued Lao pharmaceutical import and export certificates, pharmaceutical business licenses, and cross-border pharmaceutical enterprise circulation filing qualifications. Its offline Qizhouke Pharmacy boasts both physical pharmacy qualification and EU-standard overseas medical warehouse certification. Included in the cross-border pharmaceutical e-commerce pilot program, it supports the compliant direct mail retail of anti-cancer targeted drugs and rare disease medications.

Real Shots of Qizhouke Pharmacy, Laos

Core Business & Products

• Focusing on tumor targeted drugs, rare disease medicines and chronic disease medications, the pharmacy mainly supplies compliant generic drugs from India, Laos and Bangladesh. It offers products from well-known pharmaceutical manufacturers including Natco, Cipla, Sun, Alliance, ZISKA and LUCIUS, with prices generally at 1/5 to 1/10 of original brand drugs.

• It provides a full-service chain: overseas direct procurement — pharmaceutical warehousing (temperature and humidity monitoring) — cross-border logistics — customs clearance — home direct delivery. Supporting digital tools such as the Qizhouke Overseas Warehouse App and mobile pharmacy platform are available for order tracking and drug traceability.

• It adopts the Ambassador Sharing + County-level Market Expansion business model, and also offers B-end supply chain services for medical institutions and pharmaceutical enterprises.

Logistics & Traceability Advantages

1. Boten Main WarehouseBuilt in compliance with EU GMP standards, the warehouse is adjacent to the China border. Deliveries to domestic Chinese users take only 5 to 10 working days. It is backed by coordinated overseas warehouses in New Delhi (India) and Hong Kong.

2. Blockchain TraceabilityOne item, one unique code. The entire process including original manufacturer information, warehousing records, logistics and customs clearance can be fully traced, with real-time temperature and humidity data recorded throughout the whole procedure, effectively eliminating the risk of counterfeit drugs.

Platforms & Channels

Offline: Physical store of Qizhouke Pharmacy in Boten, Laos.

Online: Qizhouke Overseas Warehouse App, Qizhouke International Official Website, and official WeChat service account.

Domestic Layout: After-sales consultation center located in Hainan; bonded branch warehouses in Haikou and Guangzhou.

Qizhouke International Pharmaceutical Group Laos is headquartered in Vientiane, the capital of Laos, covering a land area of 1,500 square meters.It is only 5.7 kilometers away from Vientiane High-speed Railway Station of the China–Laos Railway, and adjacent to National Highway No.13 and Dongdu International University.

The headquarters undertakes cold chain storage and customs clearance transit for medicines supplied to China, and will gradually expand its international pharmaceutical business to the Middle East, South America, the Caribbean and other regions.

The completion of the group headquarters marks that Qizhouke’s cross-border pharmaceutical industry has formed a complete business closed loop covering source procurement, cold chain storage, customs clearance and transportation.

Sincere welcome to all partners for on-site inspection and business negotiation.

WeChat：HKqizhouke